Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

There's no place like the hospital for the holidays. And we don't mean that in a good way. But here are some ways to make it better.

The American Association of Critical-Care Nurses (AACN) is presenting the research team of Brenda Pun, DNP, RN, FCCM and E. Wesley Ely, MD, MPH, with its AACN Pioneering Spirit Award.

A recent systematic review by Vanderbilt researchers has taken a close look at the cognitive instruments used in long-term outcome studies of survivors of adult critical illness and how those test scores are interpreted.

ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose.

Jane Stories is one of many COVID-19 patients still plagued by debilitating symptoms that include achy muscles, anxiety, depression, panic attacks and cognitive impairment.

Delirium, a form of acute brain dysfunction, is widespread in critically ill patients in lower resourced hospitals, and the duration of delirium predicted both mortality and disability at six months after discharge, according to a study published in PLOS ONE.